CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Adherehealth and Levrx Technology...

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Giuliano to Lead Finance-Related...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Adherehealth and Levrx Technology...

Clinical Researchs Most Recent Developments

Clinical Researchs Most Recent...

Aceragen Receives Grant from Cystic Fibrosis Foundation to Advance Novel Therapy

Aceragen Receives Grant from Cystic...

Giuliano to Lead Finance-Related Leadership Functions as New CFO at Aeterna

Giuliano to Lead Finance-Related...

Top Ways Netsuite Transforms Life Science Industry for Good

Top Ways Netsuite Transforms Life...

Rain Therapeutics and Roche to Jointly Conduct Immunotherapy Trial Solid Tumor Treatment

Rain Therapeutics and Roche to...

China biopharma sector focuses on innovation.

China biopharma sector focuses on...

IACT Health and LMC Manna Research Announce Strategic Alliance, Creating One of North America's Largest Fully Integrated Research Networks

Life Sciences Review Life Sciences Review | Thursday, December 02, 2021
Tweet

This alliance will focus on improving service to pharmaceutical and research partners globally and advancing treatment options for patients across all therapeutic areas


Atlanta, Georgia and Toronto, Ontario – U.S.-based IACT Health and Canada-based LMC Manna Research today announced a strategic alliance to integrate their operations. As two of the clinical research industry’s most extensive site networks, the alliance creates one of the largest consolidated research networks in North America, with more than 40 sites, access to over 1.5 million patients, and more than 150 active investigators.


Shared technology, marketing, recruitment, business development, contracts, budgets, standard operating procedures, and more are expected to further expand the operational efficiencies that IACT Health and LMC Manna Research already offer the industry.


“We are thrilled to join forces with such a highly-qualified and reputable research organization that brings such deep experience and a proven track record of delivering on their clincal trials year after year,” said Dr. Jeff Kingsley, CEO of IACT Health. “Both companies share a commitment to quality, safety, patient satisfaction, and customer service that will position us as the preferred option for pharmaceutical and biotech companies, Contract Research Organizations (CROs), patients, and providers alike.”


“LMC Manna Research is excited about the opportunity to work with IACT Health’s talented team, who share our approach to integrated research sites and systems, and place strong emphasis on quality and patient experience,” said Karri Venn, President of LMC Manna Research.


“Together, we will offer sponsors and CROs a single point of contact to perform their clinical studies across North America, while providing meaningful and strategic combined research operations across these two networks to create North America’s pre-eminent clinical research network.”


As the largest U.S. network of wholly-owned clinical research sites in the southeast U.S., IACT Health strives to revolutionize research by conducting research alongside routine healthcare, as well as urgent and emergency care, while creating outstanding clinical trial experiences, improving outcomes, and lowering the risk and net cost of studies. IACT Health’s proven enrollment is more than 212 percent of the average research site, as assessed by Tufts University. Since 2005, IACT Health has contributed to helping more than 80 medications achieve FDA approvals in areas such as oncology, cardiology, pulmonology, endocrinology, infectious disease, and pain.


Canada’s most extensive clinical research network, LMC Manna Research provides pharmaceutical companies and CROs with a single source approach to performing clinical trials across a full gamut of treatment areas. Its proven track record of fast start-up, high recruitment and regulatory compliance is supported by its ability to provide single-source contracting, integrated standard operating procedures, strong quality assurance and capabilities to deploy a national decentralized technology system across its entire network.


Weekly Brief

loading
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
Top 10 Clinical Trial Services Companies - 2022
Top 10 Emerging Clinical Trial Management Companies - 2022
Top 10 Clinical Trial Management System Companies - 2022
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/iact-health-and-lmc-manna-research-announce-strategic-alliance-creating-one-of-north-america-s-largest-fully-integrated-research-networks-nwid-653.html